Welcome to kongre.net

CT

SummitIn personPast event

11th CAR-TCR Summit 2026

Hosted by Hanson Wade

15 – 17 September 2026
The Westin Boston Seaport District, Boston, United States of America
Health SciencesPharmacy & Pharmaceutical Sciences

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Welcome to kongre.net

Official website

Programme

Published

89 sessions across 3 days

84 speakers

Browse programme

Registration

Event has ended

Registration is handled by the organiser

Fees are listed on this page

View registration details

Key facts

11th CAR-TCR Summit 2026 is a summit held 15 – 17 September 2026 in The Westin Boston Seaport District, Boston, United States of America, organised by Hanson Wade.

Dates:: 15 – 17 September 2026
Format:: In person
Venue:: The Westin Boston Seaport District, Boston, United States of America
Subjects:: Pharmacy & Pharmaceutical Sciences
Organiser:: Hanson Wade
Official website:: car-tcr-summit.com

The 11th CAR-TCR Summit 2026 is the definitive global forum dedicated to CAR and TCR cell therapies. Organised by Hanson Wade, the event takes place from September 15–17, 2026, at The Westin Boston Seaport District in Boston, MA. Bringing together key stakeholders across discovery, clinical development, manufacturing, and investment, the summit highlights cutting-edge scientific innovation, clinical trial strategies, automated manufacturing processes, and commercial insights to drive long-term success in the field.

Programme highlights

View full programme

Tue, 15 Sept 2026Boosting the Efficacy of TCR- & CAR-T Cells Using a Novel TGF-beta SWITCH ReceptorOral sessionSWITCH significantly increases potency of TCR- and CAR-T cells against tumors; SWITCH receptor targeting TGF-beta, a key defense line of the hostile tumor micro20 sessions this day
Wed, 16 Sept 2026Program Directors' Welcome AddressPlenary35 sessions this day
Thu, 17 Sept 2026Chair's Opening RemarksPlenary34 sessions this day

Speakers

View all 84 speakers

Daniel Nunez
Cabaletta Bio
Proving Durable Autoimmune Responses Without Lymphodepletion to Expand Safety, Access & Clinical Impact
Matthias Bozza
CPTx
Non-Viral ssDNA Vector Delivery Strategies to Optimize Persistence & Patient Safety +1 more
Rudolph Hulspas
Dana-Farber Cancer Institute
Optimizing Starting Materials to Enable Future Scalable Cell Therapy Production
Kanya Rajangam
Senti Biosciences Inc
Roundtable Discussion: Utilizing Biomarkers to Guide Patient Selection, Predict Responses & Improve Safety +1 more
Randy Berholtz
Mesa Verde Venture Partners
Investors Panel Discussion: Shaping Cell Therapy Funding & Partnerships with Investor Perspectives
Steven Feldman
Stanford GMP Facility
Transitioning Between Viral & Non-Viral Platforms to Enhance CAR-T Safety & Durability +1 more
Felix Lorenz
Captain T Cell
Boosting the Efficacy of TCR- & CAR-T Cells Using a Novel TGF-beta SWITCH Receptor
Felix A Montero-Julian
Accellix
The Evolving Role of Blood Centers in Delivering Characterized Starting Material for CGT Manufacturing

Venue & travel The Westin Boston Seaport DistrictBoston, United States of AmericaVenue details About the organiser Hanson Wade4 more events from this organiserOrganiser profile Who is going? See who attended this eventSee who is going

Organiser and contact

Host organisation

Hanson Wade 4 more events from Hanson Wade

Contact

Event secretary:: Clarice Handley
Email:: [email protected]

Advertisement

Related events